Skip to main content
OpenTrials

Clinical trial condition

Adnexal Diseases

Explore clinical trials studying Adnexal Diseases. Study availability and eligibility vary by location and protocol.

3,512 public trials 681 recruiting studies
Refine in advanced search Browse all conditions

Adnexal Diseases trial results

Completed

Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer

NCT03759587

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Hirosaki University Hospital Hirosaki, Aomori, Japan
  • Shikoku Cancer Center Matsuyama, Ehime, Japan
  • Ehime University Hospital Tōon, Ehime, Japan
View all 27 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

NCT03629756

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • Scottsdale Healthcare Hospitals dba HonorHealth Scottsdale, Arizona, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Rocky Mountain Cancer Centers (Midtown) Denver, Colorado, United States
View all 15 locations
View Trial Details
Completed

A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies

NCT03719326

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +19 more
Locations
  • Scottsdale Healthcare Hospitals dba Honor Health Research Institute Scottsdale, Arizona, United States
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Rocky Mountain Cancer Centers (Aurora) Aurora, Colorado, United States
View all 27 locations
View Trial Details
Completed

Efficacy and Safety of SBRT in Oligo-metastatic/Persistent/Recurrent Ovarian Cancer

NCT04593381

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Responsible Research Hospital Campobasso, CB, Italy
  • S.C. di Radioterapia Oncologica-Azienda Sanitaria locale Biella, Italy
  • Azienda Ospedaliera "Cannizzaro" Catania, Italy
  • Azienda sanitaria locale Lanciano Vasto Chieti Chieti, Italy
View all 14 locations
View Trial Details

Related conditions